![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
01 JANSSEN CILAG INTERNAT.N.V. (2)
02 Janssen-Cilag AG (2)
03 Janssen-Cilag International N.V. (2)
01 IBRUTINIB (6)
01 Italy (2)
02 Norway (2)
03 Switzerland (2)
01 Capsule (2)
02 Capsule, hard (2)
03 Ibrutinib 140Mg 120 Unita' Oral Use (1)
04 Ibrutinib 140Mg 90 Combined Oral Use (1)